AMR's impact
AMR isn’t just a human health crisis, treatment-resistant disease affects animals and plants too, and it poses biosecurity and trade risks.
It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019. AMR also has significant economic costs. If not addressed, it could wipe up to $283 billion from the Australian economy by 2050.
The World Bank estimates AMR could result in US $1 trillion additional healthcare costs by 2050, and US $3.4 trillion gross domestic product (GDP) losses per year by 2030. Potential impacts of unmitigated AMR on industry and communities are far reaching – ranging from treatment failure to production failure, regulatory pressure, trade impacts and export industry disruption.